First Human Trials of Ebola Vaccine Start in U.S.

ebola
The first human clinical trials of a Canadian-developed Ebola vaccine, VSV-EBOV, begin in Maryland today to assess the vaccine’s safety and determine the appropriate dosage to fight the virus that has killed more than 4,000 people, largely in West Africa, Health Minister Rona Ambrose has announced.
“The health-care workers on the ground are the most likely target to do the next step,” which could begin by the end of the year or early 2015, he said.
The Ebola epidemic has killed more than 4,000 people, mostly in the West African countries of Liberia, Sierra Leone and Guinea, according to figures published last week

Comments

From the Web